(Q67895757)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1822804%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

title

Steroids in Duchenne muscular dystrophy--deflazacort trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1822804%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

Steroids in duchenne muscular dystrophy — Deflazacort trial (English)

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90099-E

2 December 2022

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90099-E

2 December 2022

author name string

L. E. Mesa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1822804

2 December 2022

A. L. Dubrovsky

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1822804

2 December 2022

J. Corderi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1822804

2 December 2022

P. Marco

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1822804

2 December 2022

D. Flores

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1822804

2 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1822804

2 December 2022

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1822804%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

18 September 2019

https://api.elsevier.com/content/article/PII:096089669190099E?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90099-E

https://api.elsevier.com/content/article/PII:096089669190099E?httpAccept=text/plain

2 December 2022

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90099-E

2 December 2022

published in

Neuromuscular Disorders

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1822804%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1822804%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1822804%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

page(s)

261-266

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1822804%20AND%20SRC:MED&resulttype=core&format=json

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

18 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90099-E

Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals

2 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90099-E

The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle

2 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90099-E

Prednisone in Duchenne muscular dystrophy

2 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90099-E

Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit

2 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90099-E

Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone

2 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90099-E

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

2 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90099-E

Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group

2 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90099-E

Steroids Possessing Nitrogen Atoms. III. Synthesis of New Highly Active Corticoids. [17α,16α,-d]Oxazolino Steroids

2 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90099-E

Steroids possessing nitrogen atoms. IV further studies on the synthesis of [17α,16α-d]-oxazolino-corticoids

2 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90099-E

Clinical trial in Duchenne dystrophy. I. The design of the protocol

2 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90099-E

Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy

2 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90099-E

Prednisone in Duchenne dystrophy

2 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90099-E

Randomized, double-blind trial of mazindol in Duchenne dystrophy

2 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90099-E

Weight reduction in boys with muscular dystrophy.

2 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90099-E

A new chart for weight control in Duchenne muscular dystrophy

2 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90099-E

2 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1822804%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1 reference